and a HexNAc residue, suggesting that the glycan in the m/z 966.0 2ϩ glycopeptide was linked to the peptide through HexNAc rather than DATDH (Fig. 4C, inset) . In view of the DATDH synthesis pathway (19) , it is likely that the HexNAc-linked oligosaccharide represents a precursor of the DATDH oligosaccharide ( fig. S1 ).
A number of C. jejuni N-linked glycoproteins, whose glycosylation is dependent on the pgl gene cluster, have been identified (6) . These glycoproteins have diverse functions in the cell but are all located extracytoplasmically. This is in agreement with the periplasmic space being the proposed site of PglB-mediated glycosylation in C. jejuni. The composition of the oligosaccharide did not show similarities to the highly conserved Glc 3 Man 9 GlcNAc 2 oligosaccharide that is transferred to protein in the ER of eukaryotes. However, as in eukaryotes, the protein-bound oligosaccharide in C. jejuni was linked to the amide nitrogen of asparagine within the consensus sequence Asn-Xaa-Ser/Thr. This sequence is essential for N-linked protein glycosylation in eukaryotes, and it has been proposed that it forms a specific secondary structure, the Asn-turn, recognized by the oligosaccharyltransferase (10) . The presence of this consensus sequence on glycoproteins of C. jejuni suggests that the reaction mechanisms in eukaryotes and in C. jejuni are very similar. It is proposed that PglB fulfills the oligosaccharyltransferase function in the prokaryote and that Stt3 protein represents the catalytic subunit of the eukaryotic oligosaccharyltransferase complex. With the bipartite nature of the eukaryotic N-glycosylation pathway in mind, we speculate that in C. jejuni the heptasaccharide is assembled in the cytoplasm on a lipid carrier, most likely bactoprenyl pyrophosphate, translocated to the periplasmic side of the membrane, and transferred to protein ( fig. S1 ).
To our knowledge, a general N-glycosylation system very similar to the one found in eukaryotes has not been described in other bacteria, and the C. jejuni genome is the only bacterial genome sequenced to date that harbors a gene that encodes a protein with strong sequence homology to a eukaryotic oligosaccharyltansferase component. The unique biosynthetic potential of C. jejuni and the isolated appearance of such an oligosaccharyltransferase ortholog in this organism led us to conclude that lateral gene transfer (20) of the oligosaccharyltransferase gene either from the archaeal or the eukaryal domain is responsible for this unique biosynthetic property of C. jejuni.
Note added in proof: The structure of the N-linked glycan of C. jejuni has recently been published (21 Several amidated lipids serve as endogenous signaling molecules in the mammalian central nervous system, modulating behaviors such as pain, cognition, feeding, sleep, and locomotor activity (1) (2) (3) (4) (5) . A subset of these, including anandamide (1), bind to the central cannabinoid receptor CB1, a heterotrimeric GTP-binding protein (G protein)-coupled receptor activated by the psychotropic component of marijuana, ⌬ 9 -THC (6). Additional classes of lipid transmitters have also emerged as regulators of nervous system function (7) . Nonetheless, the molecular mechanisms for regulating lipid-based signaling events remain largely unknown. Although classical neurotransmitters can be confined spatially by membrane-delineated compartments for controlled storage, release, and uptake, lipid messengers are not easily contained by such physical boundaries. Because lipids can readily partition to and diffuse throughout cell membranes, termination of their signaling capacity may rely primarily on chemical transformation, possibly within the bilayer itself, instead of on cellular uptake and compartmentalization.
The amplitude and duration of fatty acid amide signals are regulated in vivo primarily by a single degradative enzyme, the integral membrane protein fatty acid amide hydrolase (FAAH) (8) . Transgenic mice lacking FAAH possess high endogenous concentrations of anandamide and related fatty acid amides in the brain that correlate with increased CB1-dependent analgesia in these animals (9), suggesting that FAAH may represent an at- (11), malonamide (12) , and glutamine (13) . Relative to other AS enzymes, two distinguishing features of FAAH are its integration into membranes and its strong preference for hydrophobic substrates (14) . To elucidate the structural basis for these unique biochemical properties, we determined the three-dimensional structure of FAAH to 2.8 Å resolution by x-ray crystallography. Coordinates and structure factors have been deposited in the Protein Data Bank (accession code 1MT5). We obtained protein crystals by recombinantly expressing rat FAAH with 29 amino acids deleted at the NH 2 -terminus. Although the deleted region is predicted to participate in membrane binding (8) , the truncated FAAH variant (residues 30 to 579) retains the wild-type protein's association with membranes, detergent requirement for solubilization, and ability to degrade fatty acid amides in mammalian cells (15) . Crystals of FAAH The amino (N) and carboxyl (C) termini of the green subunit are labeled; Pro 129 is indicated. A genetic polymorphism conferring substitution of threonine at this position has been implicated in drug abuse and renders the enzyme more vulnerable to proteolytic attack (25) . All figures were produced with Molscript (26), GRASP (23) , and Raster3D (27) . The membrane model was generated by a Molecular Dynamics simulation of a palmitoyloleoylphosphatidylethanolamine (POPE) bilayer (28). complexed with methoxy arachidonyl fluorophosphonate, an active site-directed irreversible inhibitor, were obtained in three space groups: twinned P2 1 with 16 molecules in the asymmetric unit, C222 1 with 8 molecules in the asymmetric unit, and P6 3 22 with 2 molecules in the asymmetric unit (16) . We first determined the structure of the FAAH-inhibitor complex to 3.3 Å by using a combination MIRAS/MAD (multiple isomorphous replacement with anomalous signals/multiwavelength anomalous diffraction) phasing strategy followed by phase extension with multicrystal and NCS (noncrystallographic symmetry) averaging (Table 1 ). The resulting electron density maps displayed density for more than 90% of the side chains with no main-chain breaks, yielding an exceptional search model for molecular replacement phasing of twinned monoclinic data. The final model, built in P2 1 at 2.8 Å resolution, was of excellent quality.
The crystal structure of FAAH reveals a dimeric enzyme (Fig. 1) , consistent with chemical cross-linking studies indicating that the enzyme is a dimer in solution (15) . The dimer interface buries about 1560 Å 2 of molecular surface area per monomer (17) . The protein core is characterized by a twisted ␤ sheet consisting of 11 mixed strands, which is surrounded by 24 ␣ helices of various lengths. The overall fold of the monomer closely resembles that of malonamidase (MAE2) from the nitrogen-fixing bacterium Bradyrhizobium japonicum, the only other AS enzyme for which a structure is available (12) . However, there are key structural differences.
We identified the active site of FAAH on the basis of the location of core catalytic residues defined previously by mutagenesis (10, 18) and from the density of the inhibitor adduct methoxy arachidonyl phosphonate (MAP) (Fig. 2) . The catalytic nucleophile Ser 241 is covalently bonded to the phosphorus of the MAP molecule, and the neighboring density can be modeled to accommodate the arachidonyl chain in an energetically favorable conformation (Fig. 2A) . As observed for MAE2, the serine nucleophile in FAAH forms part of an unusual Ser-Ser-Lys catalytic triad with Ser 217 and Lys 142 (Fig. 2B) , and the relative orientation of the catalytic residues is nearly superimposable between the structures of FAAH and MAE2 (root mean square deviation ϭ 0.27 Å). In contrast, the substrate binding pockets of FAAH and MAE2 differ significantly. The tunnel leading from the surface of FAAH and containing the buried arachidonyl chain is lined with a preponderance of aromatic and aliphatic amino acids (Fig. 2B) , many of which arise from sequence insertions in FAAH relative to MAE2. These residues include Ile 491 , identified by ultraviolet crosslinking and mutagenesis studies to participate in substrate recognition (14) . In contrast, the active site of MAE2 is lined with mostly hydrophilic amino acids that accommodate its soluble substrate, malonamide (12) .
Amino acids 410 to 438, another sequence insertion in FAAH relative to MAE2, form a helix-turn-helix motif that interrupts the AS fold. The two helices ␣18 and ␣19 cap the active site and present several hydrophobic residues that likely constitute FAAH's membrane binding face (Figs. 1 and 3A) . The NH 2 -terminus of the intact enzyme, predicted by sequence analysis to form an additional membrane binding helix (amino acids 7 to 29), would be properly positioned to reinforce the membrane interactions of the ␣18 and ␣19 membrane cap (Fig. 1B) .
A potential substrate entryway is adjacent to ␣18 and ␣19, and the arachidonyl chain of MAP contacts Phe 432 of ␣18, which may indicate direct access between the FAAH active site and the hydrophobic membrane bilayer. The putative substrate entry is amphipathic in nature, with hydrophobic residues covering three sides of the rim and charged residues Arg 486 and Asp 403 completing the remaining side ( Figs. 2A and 3B ). This arrangement of residues may accommodate the admission and movement of polar fatty acid amide head groups toward the active site. Overall, the intimate relationship between the membrane binding surface and the active site of FAAH is similar to that of squalene cyclase (19) and prostaglandin H 2 synthase (20) , which also act on lipid-soluble substrates and have hydrophobic caps surrounding their respective active site entrances. In all three enzymes, the hydrophobic cap is surrounded by basic amino acids (Fig. 3B ) that may interact with negatively charged phospholipids.
A second major tunnel emerges from the active site at about an 80°angle from the arachidonyl-filled cavity. This tunnel bifurcates to create both a solvent-exposed cytosolic port and a route blocked by Trp 445 ( Fig.  2A) , a residue that forms a lock-and-key intersubunit contact. Thus, the FAAH active site appears to simultaneously access both the aqueous environment of the cytoplasm and the lipid milieu of the bilayer. This architecture may provide an exit route to the cytosol for the polar amine substituents liberated from the fatty acid amide substrates and could also provide entry for a water molecule required for deacylation of the FAAH-fatty acyl intermediate (18) .
A comparison of FAAH's structure with that of the soluble AS enzyme MAE2 reveals how a single member of a large clade of proteins has adapted to perform a specialized cellular function through the addition of discrete folding modules and without gross changes in catalytic mechanism or fold architecture (Fig. 4) . For example, although FAAH and MAE2 dimerize about roughly the same face, they have different relative monomer orientations. These distinct quaternary orientations produce an antiparallel and parallel alignment of the MAE2 and FAAH monomer active site entrances, respectively. The parallel orientation of FAAH monomers has important biological implications, because it should permit both subunits to function concurrently by recruiting substrates from the same membrane. Furthermore, this parallel alignment places another key structural module, the ␣18-␣19 hydrophobic cap, on the same face of the dimer, thereby enhancing membrane binding (Fig. 4) . Additional sequence insertions in the FAAH protein account for other specialized features of the enzyme's structure, including its cytoplasmic channel and apolar substrate binding pocket (Fig. 4) .
The intimate relationship between the active site of FAAH and cell membranes revealed by the enzyme's structure raises the possibility that fatty acid amides need not be transported through aqueous cellular compartments to proceed from site of action to site of degradation. As a consequence, proper endocannabinoid tone may rely on the expression levels of FAAH and its localization relative to cannabinoid receptor systems in vivo (21) . Finally, the structure of FAAH may facilitate the design of inhibitors that could have therapeutic benefit for a variety of nervous system disorders (22), including not only agents that bind to the enzyme acyl chain pocket but also compounds that target the active site via the cytoplasmic channel. The latter class of inhibitors might display exceptional selectivity for FAAH relative to the more than 100 lipid hydrolases present in the human proteome.
Supporting Online Material www.sciencemag.org/cgi/content/full/298/5599/1793/ DC1 Materials and Methods Table S1 Figs. S1 to S3 Fig. 4 . Proposed modular adaptations that convert a soluble enzyme to an integral membrane enzyme, as inferred from differences in the structures of FAAH and MAE2. The soluble enzyme, if oligomeric, reorganizes so that all active sites can concurrently access the bilayer for maximal efficiency. The addition of discrete structural elements, represented here in red, confers the new oligomerization domain (Trp 445 and residues 299 to 314) (lower left) as well as a membrane binding face (lower middle left) and cytoplasmic access channel (lower middle right). The final monotopic integral membrane enzyme must also undergo mutation of key substrate binding residues in the active site to effectively recruit its hydrophobic targets from the lipid bilayer (lower right).
